Relapsing Polychondritis in a Patient with Ankylosing Spondylitis under Two Different Tumor Necrosis Factor Alpha Inhibitors Treatment.
Polychondritis
TNF alpha inhibitor
adverse event
Journal
La Clinica terapeutica
ISSN: 1972-6007
Titre abrégé: Clin Ter
Pays: Italy
ID NLM: 0372604
Informations de publication
Date de publication:
04 Apr 2022
04 Apr 2022
Historique:
entrez:
6
4
2022
pubmed:
7
4
2022
medline:
9
4
2022
Statut:
ppublish
Résumé
Relapsing polychondritis (RP) is a rare autoimmune disease char-acterized by multi-systemic involvement characterized by recurrent and progressive inflammation of the cartilaginous tissue. Auricular inflammation is a characteristic finding of RP. Anti-tumor necrosis fac-tor alpha (anti-TNF) is a highly effective drug used in the treatment of inflammatory arthritis. There are several case reports showing potential relationship between the RP development and anti-TNF treatment. Here, we present a case of RP in a patient with ankylosing spondylitis under the two different tumor necrosis factor alpha inhibitors therapy.
Identifiants
pubmed: 35385029
doi: 10.7417/CT.2022.2400
doi:
Substances chimiques
Tumor Necrosis Factor Inhibitors
0
Tumor Necrosis Factor-alpha
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM